Riskpilot← Back to searchSign inGet full accessFENSMARK FYSIOTERAPI ApS
APSActiveCVR 28862555Stenskovvej 44Physiotherapy activities · NACE 8695Est. 200515 employees
Revenue 2024
DKK 3,5M
+10% vs 2023
EBITDA margin
29.4%
+11% vs 2023
Equity ratio
39.4%
Financial strength
Net profit 2024
DKK 443K
+43% vs 2023
| Revenue | DKK 3,5M | +10% |
| EBITDA | DKK 1M | +11% |
| Net profit | DKK 443K | +43% |
| Total assets | DKK 5,6M | +24% |
| Equity | DKK 2,2M | +7% |
| Employees | 15 | — |
Legal name
FENSMARK FYSIOTERAPI ApS
CVR number
28862555
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
28. juni 2005
Share capital
DKK 50.000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er fysioterapi og dermed beslægtet virksomhed.
Address
Stenskovvej 44
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.658 | 1.497 | 1.497 | 1.625 | 1.555 | 1.672 | 1.979 | 2.487 | 2.124 | 2.489 | 2.621 | 3.191 | 3.499 |
| Staff expenses | -809 | -822 | -919 | -971 | -1.009 | -1.152 | -1.231 | -1.548 | -1.560 | -1.417 | -1.502 | -2.191 | -2.472 |
| EBITDA | 849 | 675 | 578 | 654 | 120 | 521 | 747 | 940 | 564 | 1.072 | 1.119 | 930 | 1.028 |
| Depreciation & amort. | 196 | 425 | 75 | 91 | -142 | -91 | -86 | -82 | -98 | -124 | -226 | -407 | -398 |
| EBIT | 654 | 250 | 503 | 563 | -22 | 430 | 662 | 858 | 466 | 948 | 893 | 523 | 629 |
| Net financials | -83 | -51 | -73 | -92 | -78 | -133 | -79 | -60 | -253 | -54 | -104 | -150 | -204 |
| Profit before tax | 570 | 199 | 430 | 471 | -100 | 296 | 582 | 798 | 213 | 894 | 789 | 373 | 425 |
| Tax | 151 | 123 | 106 | 112 | 73 | 69 | 129 | 183 | 93 | 207 | 317 | 65 | -17 |
| Net profit | 420 | 76 | 324 | 359 | -173 | 228 | 453 | 615 | 120 | 687 | 473 | 309 | 443 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.218 | 4.798 | 6.725 | 6.838 | 6.187 | 7.700 | 6.946 | 7.026 | 7.110 | 7.381 | 10.006 | 4.555 | 5.637 |
| Equity | 2.344 | 2.040 | 2.266 | 2.525 | 2.251 | 2.375 | 2.723 | 3.230 | 3.239 | 3.813 | 4.171 | 2.079 | 2.222 |
| Long-term debt | 2.380 | 2.284 | 3.476 | 3.153 | 2.869 | 2.925 | 2.667 | 2.457 | 2.339 | 2.003 | 2.415 | 651 | 1.093 |
| Short-term debt | 432 | 415 | 915 | 1.094 | 1.012 | 2.341 | 1.497 | 1.273 | 1.456 | 1.483 | 3.147 | 1.277 | 1.964 |
| Total debt | 2.812 | 2.699 | 4.391 | 4.247 | 3.881 | 5.266 | 4.163 | 3.730 | 3.795 | 3.486 | 5.562 | 1.929 | 3.057 |
EBITDA margin
29.4%
This company
15.8%
Market median
+86% vs market
20122024
Equity ratio
39.4%
This company
38.2%
Market median
+3% vs market
20122024
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20122024
Net profit margin
12.7%
This company
8.1%
Market median
+57% vs market
20122024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20122024
Debt / equity
1.54×
This company
0.62×
Market median
-148% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EB Management | Management | 2005 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
E Bech Holding ApS | Company | 100.0% | 66.7% | 2023 |
A Bech Christiansen Holding ApS | Company | 20.0% | 20.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
A Bech Christiansen Holding ApS
FENSMARK FYSIOTERAPI ApS Board members of FENSMARK FYSIOTERAPI ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Bech Jensen | Management | 0 companies |